# The Nuvigil and Provigil Pregnancy Registry

> **NCT01792583** · — · TERMINATED · sponsor: **Cephalon, Inc.** · enrollment: 191 (actual)

## Conditions studied

- Narcolepsy
- Obstructive Sleep Apnea
- Shift Work Sleep Disorder

## Interventions

- **DRUG:** Modafinil/armodafinil

## Key facts

- **NCT ID:** NCT01792583
- **Lead sponsor:** Cephalon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06-30
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 191 (ACTUAL)
- **Why stopped:** The study is no longer feasible.
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792583, "The Nuvigil and Provigil Pregnancy Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01792583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*